Alexandrino Larissa Dias, Alencar Cristiane de Melo, Silveira Ana Daniela Silva da, Alves Eliane Bemerguy, Silva Cecy Martins
Universidade Federal do Pará, Belém, PA, Brasil.
J Appl Oral Sci. 2017 May-Jun;25(3):335-340. doi: 10.1590/1678-7757-2016-0408.
This randomized, controlled, double-blind clinical study evaluated the effect of calcium sodium phosphosilicate (NovaMin) and casein phosphopeptide-amorphous calcium phosphate with fluoride (CPP-ACPF) on the prevention of post-operative sensitivity and on the effects of clinical bleaching treatment.
Sixty volunteers were selected according to inclusion and exclusion criteria and were randomly assigned into three groups (n=20): CG (control group) patients, who were treated with 35% hydrogen peroxide; NOVAG (NovaMin group) patients, who were treated with 35% hydrogen peroxide followed by the application of NovaMin; and CPPG (CPP group) patients, who were treated with 35% hydrogen peroxide followed by the application of CPP-ACPF. Both bioactive agents were applied for five minutes. An evaporative stimulus associated with a modified visual scale was used to analyze sensitivity 24 hours after each bleaching session. The color evaluation was performed on the maxillary central incisors using a spectrophotometer. Associations between the intervention group, bleaching session, and reported sensitivity were tested using Chi-square partitioning.
Color change values (ΔE) were analyzed using analysis of variance (ANOVA). The significance level used for both tests was 5%. In the intragroup assessment, the Friedman test showed that only the CPP-ACPF group showed no statistically significant difference (p<0.05) between baseline and first bleaching session. In the intergroup assessment, the Kruskal-Wallis test showed that the CPPG had less postoperative sensitivity after the first session, when compared to the other groups (p<0.05). Color change analysis (ΔE) showed a significant difference between the means obtained in the different bleaching sessions in all groups (p<0.05).
This study showed that the combination of CPP-ACPF with 35% hydrogen peroxide significantly reduced post-operative sensitivity in the first session, compared with the other evaluated treatments. The association of CPP-ACPF and NovaMin did not affect the color change induced by tooth bleaching.
本随机、对照、双盲临床研究评估了磷酸硅钙钠(NovaMin)和含氟酪蛋白磷酸肽 - 无定形磷酸钙(CPP - ACPF)对预防术后敏感性以及对临床漂白治疗效果的影响。
根据纳入和排除标准选取60名志愿者,随机分为三组(n = 20):CG(对照组)患者,用35%过氧化氢治疗;NOVAG(NovaMin组)患者,先用35%过氧化氢治疗,随后应用NovaMin;CPPG(CPP组)患者,先用35%过氧化氢治疗,随后应用CPP - ACPF。两种生物活性制剂均应用5分钟。在每次漂白疗程后24小时,使用与改良视觉量表相关的蒸发刺激来分析敏感性。使用分光光度计对上颌中切牙进行颜色评估。使用卡方分割检验干预组、漂白疗程和报告的敏感性之间的关联。
使用方差分析(ANOVA)分析颜色变化值(ΔE)。两种测试使用的显著性水平均为5%。在组内评估中,Friedman检验表明,只有CPP - ACPF组在基线和首次漂白疗程之间未显示出统计学显著差异(p < 0.05)。在组间评估中,Kruskal - Wallis检验表明,与其他组相比,CPPG组在首次疗程后术后敏感性较低(p <